Although the roles of cAMP – PKA/EPAC in lipid homoeostasis-related cardiovascular diseases are mostly in the basic research stage, these findings indicate that this signalling pathway has certain preventive and therapeutic value. Here, RAPGEF3 is linked to cardiovascular disorder.